CYMODIQ

Serial Number 86861586
606

Registration Progress

Application Filed
Dec 30, 2015
Under Examination
Nov 1, 2016
Approved for Publication
Sep 6, 2016
Published for Opposition
Sep 6, 2016
Registered

Trademark Image

CYMODIQ

Basic Information

Serial Number
86861586
Filing Date
December 30, 2015
Published for Opposition
September 6, 2016
Abandonment Date
December 2, 2019
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Dec 2, 2019
Classes
005

Rights Holder

Pfizer Inc.

03
Address
235 East 42nd Street
New York, NY 10017

Ownership History

Pfizer Inc.

Original Applicant
03
New York, NY

Pfizer Inc.

Owner at Publication
03
New York, NY

Legal Representation

Attorney
Katrina Edge

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

40 events
Date Code Type Description Documents
Dec 2, 2019 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Dec 2, 2019 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Apr 13, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 12, 2019 EX5G S SOU EXTENSION 5 GRANTED Loading...
Apr 8, 2019 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 8, 2019 EXT5 S SOU EXTENSION 5 FILED Loading...
Oct 13, 2018 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 11, 2018 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 11, 2018 EXT4 S SOU EXTENSION 4 FILED Loading...
Oct 11, 2018 EX4G S SOU EXTENSION 4 GRANTED Loading...
Jun 21, 2018 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 20, 2018 EX3G S SOU EXTENSION 3 GRANTED Loading...
Jun 19, 2018 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Jun 1, 2018 DOCK D ASSIGNED TO EXAMINER Loading...
May 4, 2018 PROA I TEAS PETITION TO REVIVE RECEIVED Loading...
May 4, 2018 PETG O PETITION TO REVIVE-GRANTED Loading...
May 4, 2018 TPEX I SOU EXTENSION RECEIVED WITH TEAS PETITION Loading...
May 4, 2018 NREV E NOTICE OF REVIVAL - E-MAILED Loading...
May 1, 2018 EXT3 S SOU EXTENSION 3 FILED Loading...
Oct 5, 2017 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 3, 2017 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 3, 2017 EXT2 S SOU EXTENSION 2 FILED Loading...
Oct 3, 2017 EX2G S SOU EXTENSION 2 GRANTED Loading...
Mar 24, 2017 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 22, 2017 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 22, 2017 EXT1 S SOU EXTENSION 1 FILED Loading...
Mar 22, 2017 EX1G S SOU EXTENSION 1 GRANTED Loading...
Nov 1, 2016 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Sep 6, 2016 PUBO A PUBLISHED FOR OPPOSITION Loading...
Sep 6, 2016 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Aug 17, 2016 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Aug 2, 2016 ALIE A ASSIGNED TO LIE Loading...
Aug 2, 2016 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Jul 21, 2016 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 10, 2016 CNSL R SUSPENSION LETTER WRITTEN Loading...
Mar 10, 2016 GNSL F LETTER OF SUSPENSION E-MAILED Loading...
Mar 10, 2016 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Loading...
Mar 8, 2016 DOCK D ASSIGNED TO EXAMINER Loading...
Jan 8, 2016 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jan 2, 2016 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations, and tissue repair preparations; vaccines for human use
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005